Voluntary announcement - abbisko therapeutics' lavengratinib (ABSK061) for the treatment of achondroplasia granted orphan designation by ema
Filed with HKEX · Stock code 2256 ·
6ix is reading this filing.
View original source (HKEXnews)Abbisko Cayman Limited on 6ix
Earlier from Abbisko Cayman
- Next Day Disclosure Returns
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow Abbisko Cayman into a list and get an email when it puts out news.
Follow Abbisko Cayman